Login with your work email address to view charts. No credit card required.
| Art Unit: | 1635 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 536 — Organic compounds -- part of the class 532-570 series 435 — Chemistry: molecular biology and microbiology 424 — Drug, bio-affecting and body treating compositions 324 — Electricity: measuring and testing 604 — Surgery 414 — Material or article handling 370 — Multiplex communications 800 — Multicellular living organisms and unmodified parts thereof and related processes |
| Phone: | (571) 272-0758 |
| Email: | terra.gibbs@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr (Biolgy) |
| Service: | 24 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 54% over 407 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 78th
|
With Examiner Gibbs, you have a 54% chance of getting an issued patent by 3 years after the first office action. Examiner Gibbs is a harder examiner and in the 78th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Gibbs, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Gibbs's grant rate is higher than that of Art Unit 1635 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Gibbs | 1.7 |
| Art Unit 1635 | 1.6 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.